Printer Friendly

Articles from MondayMorning (February 22, 2010)

1-26 out of 26 article(s)
Title Author Type Words
Allergan Inc's (Irvine CA) Botox, given in the doses used to reduce facial wrinkles, may stop certain kinds of migraines that patients describe as crushing or "eye-popping" more than other types, a study found. 295
Astra paying over $2 billion for Rigel arthritis drug. AstraZeneca Plc. 394
Auxilium Pharmaceuticals Inc. Brief article 242
Billionaire investor Carl Icahn cut his stake in search firm Yahoo Inc (Sunnyvale CA) but added shares in biotechnology company Genzyme Corp (Cambridge MA), securities filings show. Brief article 265
Blood tests derived from the DNA of cancer patients' tumors will offer doctors a new way to determine whether the patients' treatment has eliminated the disease, a study said. Report 408
Breast cancer survivors who take aspirin regularly may be less likely to die or have their cancer return, US researchers reported. Brief article 294
Cardionet Inc. Brief article 203
Cholesterol levels, blood pressure and family history remain better indicators for determining which women will develop heart disease than genetic screening, a study found. 333
Cryolife Inc. Brief article 233
FDA roundup: EnterMed Inc. 1033
Former US Representative Billy Tauzin, a major player in the healthcare reform debate, resigned as head of the Pharmaceutical Research and Manufacturers of America. Brief article 127
Genzyme Corp. Brief article 313
IPO sector. 346
Markets: the stock market ended a strong week with modest gains Friday after investors divined good news in the Federal Reserve's decision to begin dismantling emergency lending measures for banks. 351
Medical stock spotlight: molecular insight Pharmaceuticals Inc. 728
New drug class offers hope against "superbugs". 324
Obama will offer compromise health plan. Brief article 282
One in five Europeans say they have bought prescription drugs on the Internet without a doctor's guidance, according to a survey funded by Pfizer Inc (New York). Brief article 243
Premiums jump 14% for Medicare private plans. 392
Schering-Plough acquisition boosts Merck 4Q profit. Merck & Co. Financial report 396
Solvay 4Q profit soars; sees challenging 2010. Brief article 216
Teva 4Q profit rises; maintains 2010 view. Teva Pharmaceutical Industries Ltd. Brief article 283
The US Food and Drug Administration is reviewing potential risks of medicines from Swiss drugmakers Roche Holding AG and Novartis AG, and other companies. 229
Tracking Washington. 422
Weekly key rates. Brief article 110
Weekly stock performance. Statistical table 454

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters